AbbVie
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
28.2724.5714.0612.85
Price/Sales ratio
6.275.855.505.18
Earnings per Share (EPS)
$7.31$8.40$14.69$16.07

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
58.8318.7117.0629.0724.9816.6338.6920.7624.1856.3461.4724.98
Price/Sales ratio
5.224.213.965.474.333.943.894.264.935.045.664.33
Price/Book Value ratio
59.9124.4021.9030.28-16.82-16.0413.6615.5516.5826.4452.20-16.82
Price/Cash Flow ratio
29.4112.7714.4215.4910.589.8410.1510.5211.4711.9919.0710.58
Price/Free Cash Flow ratio
35.5313.7415.4716.3611.1010.2610.6310.8911.8012.4120.1311.10
Price/Earnings Growth ratio
-1.030.101.07-3.122.170.38-0.790.159.21-0.950.720.72
Dividend Yield
2.54%3.42%3.65%2.66%3.92%4.85%4.31%3.86%3.50%3.84%3.48%4.85%
Profitability Indicator Ratios
Gross Profit Margin
77.82%80.31%77.24%75.04%76.43%77.63%66.40%68.95%70.00%62.41%76.84%76.43%
Operating Profit Margin
17.08%32.97%36.43%33.82%19.48%39.02%24.80%31.89%31.20%23.48%24.88%19.48%
Pretax Profit Margin
11.86%29.06%30.75%27.38%15.86%25.32%7.41%23.11%23.21%11.50%12.95%25.32%
Net Profit Margin
8.88%22.50%23.21%18.81%17.36%23.69%10.07%20.53%20.38%8.95%9.22%23.69%
Effective Tax Rate
25.11%22.58%24.49%31.29%9.42%6.45%36.02%11.08%12.10%22.03%28.67%9.42%
Return on Assets
6.44%9.69%9.00%7.50%9.58%8.84%3.06%7.87%8.52%3.61%3.57%8.84%
Return On Equity
101.83%130.39%128.40%104.15%-67.33%-96.45%35.30%74.90%68.59%46.94%65.71%-67.33%
Return on Capital Employed
21.16%17.87%16.58%17.62%15.15%17.65%9.32%16.09%16.58%13.16%13.77%17.65%
Liquidity Ratios
Current Ratio
1.411.491.651.270.983.170.84N/AN/AN/A0.643.17
Quick Ratio
1.311.331.501.170.883.060.720.700.840.760.543.06
Cash ratio
0.730.770.520.550.422.560.290.270.310.330.162.56
Days of Sales Outstanding
68.3075.5267.7365.8159.9959.5570.3064.8070.7574.9575.4059.99
Days of Inventory outstanding
92.69139.4390.3583.2175.9088.9578.5165.4475.0173.28126.3475.90
Operating Cycle
160.99214.95158.09149.03135.90148.51148.81130.24145.77148.24201.74135.90
Days of Payables Outstanding
115.53129.5388.0476.4273.1171.2453.9860.2961.4965.93N/A71.24
Cash Conversion Cycle
45.4585.4270.0572.6062.7877.2694.8269.9484.2782.30201.7462.78
Debt Ratios
Debt Ratio
0.540.590.550.520.670.740.570.520.450.440.490.74
Debt Equity Ratio
8.598.027.947.33-4.77-8.166.584.973.665.7311.78-4.77
Long-term Debt to Capitalization
0.850.880.880.851.311.140.850.800.770.830.901.14
Total Debt to Capitalization
0.890.880.880.871.261.130.860.830.780.850.921.13
Interest Coverage Ratio
7.9510.488.968.344.737.275.11N/AN/AN/A5.434.73
Cash Flow to Debt Ratio
0.230.230.190.260.330.190.200.290.390.380.230.19
Company Equity Multiplier
15.7913.4414.2513.88-7.02-10.9011.519.508.0413.0023.77-7.02
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.170.320.270.350.400.400.380.400.420.420.290.40
Free Cash Flow / Operating Cash Flow Ratio
0.820.920.930.940.950.950.950.960.970.960.940.95
Cash Flow Coverage Ratio
0.230.230.190.260.330.190.200.290.390.380.230.19
Short Term Coverage Ratio
0.793.0917.511.552.523.552.061.826.033.171.313.55
Dividend Payout Ratio
150%64.03%62.43%77.35%98.11%80.76%167.15%80.23%84.85%216.71%212.78%98.11%